BridgeMD
New treatment option for Down Syndrome (DS)
Official title The Effect of the HEP Approach in Infants With Down Syndrome
ClinicalTrials.gov ID: NCT07163780
What this study is testing
- What it's testing
- This study evaluates the effect of the HEP (Homeostasis-Enrichment-Plasticity) approach on motor and sensory development in infants with Down syndrome. Thirty-two infants will receive either HEP or traditional therapy over 12 sessions, and outcomes will be measured using standardized developmental tests.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 12
You may be able to join if
- Must be between 4 and 12 months old
- Must have been diagnosed with Down Syndrome
- Must not be at any neurological risk
- Parent must agree to participate regularly in the study process
You likely can't join if
- History of intraventricular hemorrhage (Grade III or IV)
- Major vision or hearing impairment
- History of febrile convulsion
- Medical conditions (e.g., oxygen dependence) that prevent active participation in the study
- Participation in other experimental rehabilitation studies
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Beykoz, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 months to 12 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Beykoz, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.